Search Results - Mini Michael
- Showing 1 - 1 results of 1
-
1
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial by Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, Hadas Shasha-Lavsky, David J. Sas, Mini Michael, Anne-Laure Sellier-Leclerc, Julien Hogan, Richard Willey, John M. Gansner, Daniella Magen
Published in Frontiers in Pediatrics (2024-09-01)Get full text
Article
